Scott Garrett

Scott Garrett Email and Phone Number

Commercial Executive Driving Innovation and Launch Success @ GRAIL
Scott Garrett's Location
San Diego County, California, United States, United States
Scott Garrett's Contact Details
About Scott Garrett

Passionate commercial leader with significant launch experience and track record of building shareholder value in multiple life science categories. Broad experience across Marketing, Sales, Analytics, Product Development, Market Access, Advocacy, Health Economics, Business Development and Alliance Management. Significant experience recruiting and leading high-performing teams to achieve challenging commercial goals in start-up, mid-size and large organizations. Areas of experience include hematology, cardiology, oncology, neuroscience, critical care, radiopharmaceuticals and diagnostics.

Scott Garrett's Current Company Details
GRAIL

Grail

View
Commercial Executive Driving Innovation and Launch Success
Scott Garrett Work Experience Details
  • Grail
    Vice President, Commercial Strategy
    Grail Aug 2023 - Present
    Menlo Park, Ca, Us
    Our mission is to detect cancer early, when it can be cured. We are using the power of next-generation sequencing (NGS), state-of-the-art data science, and population-scale studies to overcome one of medicine’s greatest challenges. Our clinical trials include >350,000 patients.
  • Bristol Myers Squibb
    Vice President, Marketing Strategy And Commercial Analytics
    Bristol Myers Squibb Nov 2020 - Jun 2023
    Lawrence Township, Nj, Us
    Focused on building teams and capabilities for Turning Point Therapeutics first product launch, a best-in-class treatment for ROS1+ lung cancer. Commercial lead on partnering process leading to $4.1B acquisition by Bristol Myers Squibb.
  • Portola Pharmaceuticals, A Subsidiary Of Alexion Pharmaceuticals
    Vice President, Strategic Marketing
    Portola Pharmaceuticals, A Subsidiary Of Alexion Pharmaceuticals 2017 - 2020
    Go-to-market planning and broad commercial responsibilities for two hematology products with FDA fast-track and breakthrough therapy designation. Recruited and led a high-performing team, oversaw a $30M budget and achieved launch-year (ANDEXXA®) net revenue of $110M from 600+ accounts followed by Alexion Pharma acquisition for $1.2B.
  • Huya Bioscience International (Private, Gho Capital Funded)
    Vice President, Portfolio Planning
    Huya Bioscience International (Private, Gho Capital Funded) 2016 - 2016
    Global portfolio planning for oncology and CV pipeline.
  • Celladon Corporation
    Vice President, Commercial Planning
    Celladon Corporation 2015 - 2015
    Global commercial planning, analytics and forecasting for a breakthrough gene therapy drug candidate in development for advanced cardiomyopathy.
  • Mallinckrodt Pharmaceuticals
    Vice President, Marketing And Heor, Hospital Products
    Mallinckrodt Pharmaceuticals 2011 - 2014
    Dublin, Ireland, Ie
    Joined Cadence Pharmaceuticals to launch OFIRMEV® (acetaminophen injection), benefiting millions of patients with a non-narcotic option for post-operative pain relief and becoming the most successful branded IV drug launch in the U.S. by unit volume. Responsible for all elements of the marketing mix, health economics (HECON) model and payer value proposition. Achieved $250M revenue by year 3 leading to $1.4B acquisition by Mallinckrodt and formation of the MNK Critical Care business unit.
  • Gilead Sciences
    Senior Director, Marketing
    Gilead Sciences Mar 2007 - Mar 2011
    Foster City, Ca, Us
    Recruited by CV Therapeutics Inc. to lead planning of a major label expansion for RANEXA® (ranolazine), a novel anti-anginal drug with $800M peak revenue. Designed award-winning creative launch campaign with transformative positioning, messaging and targeting plan to capture value of expanded label. Bridged Marketing team to Gilead after $1.5B acquisition and led the Ischemic Heart Disease business unit.
  • Johnson & Johnson
    Director, Marketing
    Johnson & Johnson 2002 - 2007
    New Brunswick, Nj, Us
    Joined Bay Area biotech pioneer Scios Inc to launch NATRECOR® (nesiritide), the most successful acute-care cardiovascular drug launch in the U.S. by first four-year revenue. Program Lead for ADHERE® National Heart Failure Registry which enrolled over 100,000 patients and produced >40 publications in major journals including NEJM. Continued momentum with J&J after $2.3B acquisition.
  • Boston Scientific
    Sr. Product Development Manager
    Boston Scientific 2001 - 2002
    Marlborough, Ma, Us
    Life-cycle planning for the intra-vascular ultrasound BU, a $250M franchise. Commercial Program Leader for TAXUS® coronary stent sizing initiative leading to approval of blockbuster drug-eluting stent platform. Embedded with the bio-engineering team and got to play with cool endovascular toys and gadgets.
  • Ge Healthcare (Previously Nycomed Amersham)
    Various Commercial Roles
    Ge Healthcare (Previously Nycomed Amersham) 1992 - 1999
    Chicago, Us
    Sales, Market Research and Product Management roles at Nycomed-Amersham (now G-E Health) the world leader for in-vivo diagnostic testing agents. Served on launch teams for novel/first-in-class parenteral agents for the detection of acute deep-vein-thrombosis, Parkinson's disease and liver cancer. Led Marketing efforts for CERETEC® (Tc-99 exametazime), a radiopharmaceutical approved for cerebral blood flow mapping as well as radio-labeling white blood cells.

Scott Garrett Skills

Product Launch Biotechnology Pharmaceutical Industry Cardiology Product Management Market Research Medical Devices Pharmaceutical Sales Product Development Hospitals Marketing Cross Functional Team Leadership Oncology Strategy Medicine Biopharmaceuticals Start Ups Managed Care Business Planning Hospital Sales Forecasting

Scott Garrett Education Details

  • Uc Irvine
    Uc Irvine
    Information Technology
  • San Diego State University
    San Diego State University
    Marketing

Frequently Asked Questions about Scott Garrett

What company does Scott Garrett work for?

Scott Garrett works for Grail

What is Scott Garrett's role at the current company?

Scott Garrett's current role is Commercial Executive Driving Innovation and Launch Success.

What is Scott Garrett's email address?

Scott Garrett's email address is sc****@****ics.com

What is Scott Garrett's direct phone number?

Scott Garrett's direct phone number is +165024*****

What schools did Scott Garrett attend?

Scott Garrett attended Uc Irvine, San Diego State University.

What skills is Scott Garrett known for?

Scott Garrett has skills like Product Launch, Biotechnology, Pharmaceutical Industry, Cardiology, Product Management, Market Research, Medical Devices, Pharmaceutical Sales, Product Development, Hospitals, Marketing, Cross Functional Team Leadership.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.